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Foreword 
An ldea Became Reality 
November 1994: 
Stephan Preusche, head of the Rossendorf PET cyclotron CYCLONE 1819 stayed for 
two weeks at the medical cyclotron of the Montreal Neurological Institute. During his 
work at the MN1 "CYCLONE 1819 he felt that it would be necessary and very helpful to 
come in close contact to all other CYCLONE 1819 users. 
Stephan put forward his idea of the foundation of a world wide 
CYCLONE 1819 USER COMMUNITY 
to his Canadian colleagues and he went down well. 
The aims of the community should be: 
- to come in contact with all other CYCLONE 1819 users 
- to have competent partners for discussion and 
- to change experiences of operation and maintenance of the CYCLONE 1819. 
Back home Stephan elaborated and pursued the idea of establishing a forum for 
CYCLONE 1 819 users. 
October 1996: 
Two years later. Users of CYCLONE 1819 facilities (existing and under planing) agreed 
with the idea, and our institute organizes the first workshop of the new wmmunity. 
I am pleased and honoured to welcome the participants of the first workshop of the 
CYCLONE 1819 USER COMMUNIN to Rossendorf. The participants are from all 
CYCLONE 1819 facilities around the world and, of Course, from IBA - the manufacturer 
of the PET cyclotron CYCLONEI 819. I wich all of them two busy, fruitful and pleasant 
days at RossendorflDresden. 
Prof. Bernd Johannsen 
Director of the Institute of Bioinorganic 
and Radiopharmaceutical Chemistry 
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I. REPORTS 
THE CYCLOTRON CYCLONE 1819 IN BAD OEYNHAUSEN 
P. Gerken, G. Notohamiprodjo 
Herz- und Diabeteszentrurn NRW, Institut für molekulare Biophysik, Radiophamazie und 
Nuklearmedizin, Georgstraße 11, 32545 Bad Oeynhausen 
1. lntroduction 
The Herz-und Diabeteszentrum Nordrhein-Westfalen is a hospital specialized in diagnostics and 
rnedical treatrnent of cardiovascular diseases and diabetes rnellitus. 
The PET - Center including cyclotron and radiochemistry is a part of the Institut für molekulare 
Biophysik, Radiophamazie und Nuklearmedizin and completes the traditional nuclear rnedicine . 
In May 1993 the PET carnera ( Siemens ECAT 951lA ) started working with 2-FDG ordered by KFA 
Jülich. The installation of the cyclotron started in January 1994 with the cyclotron and the yields being 
accepted in May. After the installation of the cornplete exhaust air ernission rneasuring systern in 
August 1994 the license to run the cyclotron was granted. We started with the production of [F181 - 
fluorine and the synthesis of [F181 2-FDG. In March 1995 the first patient could be exarnined with our 
own tracer. At the rnornent we have up to 6 patients a day ( tracers : [F181 2 - FDG, [NI31 - arnrnonia 
and [C l  I] - acetate, for the next future [Cl I] - rnethionine , [F181 - FTHA only scientific interest). 
2. Building 
2. I. Description 
The PET carnera, the cyclotron vault , the hotcells and the laboratories are located in the basernent of 
a new part of the hospital. 
The walls of the cyclotron vault are rnade of concrete including baryt. The door to the vault is filled with 
lead and paraffin and has a special sealing filled with cornpressed air when the door is closed. The 
doors to the laboratories and the Scanner roorn are filled with lead. 
The produced radioactivity is transported to the laboratory via polyethylene tubes for the liquids ( ID 0.5 
rnrn for fluorine and ID 0.8 rnrn for arnrnonia ) and stainless steel tubes for the gases. Both so& are 
lying in a lead tube ( ID 30 rnrn ) which is placed in the basernent of the PET center. The distance 
between cyclotron and hot cells is about 20 rn , between cyclotron and Scanner is about 25 m, so that 
we can collect the produced radionuclides after about 30 sec. 
A liquid waste systern, a cornpressor systern for waste gases and a part of the ventilation systern is 
located in the cellar of the PET center . 
The radiochernistry is equipped with 3 hotcells which have been installed by Van Gahlen, several fume 
hoods and HPLCs , GC , TLC, y-spectrornetry, pH-rneter and a LAL test for the quality control. 
2.2. Layout 
Waste roorn, gas dristibution 
Power supply roorn 
Laboratory 
Technical equipment 
Control roorn 
Vault 
Hot Lab 
Serni Hot Lab 
3. Targets and modules 
At the rnoment 4 targets frorn IBA are installed which are not positioned for the dual bearn mode. 
The srnall '* F - target deliver a suficient arnount of 2 - FDG to supply the PET for the whole day. 
Ammonia is produced for each exarnination so that a good cooperation with the PET tearn is required. 
Acetate is so far not applied routinely. 
Targets: 
18 F - Fluorine ( ma l l  volurne 300p1 ) 
13 N - Nitrogen-Arnrnonia 
11 C - Carbon 
15 0 - Oxygen 
routinely 15 GBq EOB at 12 pA for 45 rnin. 
rnax. 26 GBq EOB at 12 pA for 90 rnin. 
routinely 5 GBq EOB at 12 pA for 10 rnin. 
rnax. 9.5 GBq EOB at 15 pA for 20 rnin. 
routinely 9.5 GBq EOB at 12 pA for 10 rnin. 
rnax. 25 GBq EOB at 12 pA for 20 rnin. 
no experience, only acceptance test 
Table 1 : Overview of the isotope production and the breakdowns in 1995 and 1996 (until rnay) 
1995 (2160h ) 1996 ( until May 832 h ) 
Target hours bearn % Activity [GBq] hours bearn % Activity [GBq] 
I I* F- 125.6 5.8 1756 40.63 4.9 650 
Maintenancellnstallation 160 7.4 64 7.6 
Failures 152 7 24 2.9 
At the rnornent the radiochernistry is equipped with 5 rnodules 
2- [ I8  F] - FDG 
[ I8  F] - FTHA 
[ I  I C] - acetate 
[ I  1 C] - rnethionine 
[150]-water 
The [ I5  01 - water rnodule has been supplied by IBA, the others by Nuclear Interface. At the rnornent 
we use only the optirnized FDG rnodule ( about 200 FDG synthesis ) for routine production. Arnrnonia 
is produce directly in the target which rnakes production very easy. The anion exchange resin for the 
purification of arnrnonia is placed in the acetate rnodule so that we can use one GM counter to 
deterrnine the produced quantity. The first rnethionine synthesis tests are finished and we hope that we 
can use [ I  1 C] - rnethionine soon for patient application. 
Yield (c.f.d): FDG 45 % ,53 rnin. time of synthese 
FTH A 15 % , 120 min. 
Acetate 40 % , 12 rnin. 
Arnrnonia 98 % , on Iine 
4. Safety and security mesurements , environmental care 
4.1. Ventilation systern general 
The ventilation systern is divided into different zones. In each Zone there is a special low pressure, 
which is controlled and indicated. The cyclotron vault and the hotlab with the hotcells have the highest 
low pressure. ( cyclotron vault - 200 Pa , hotlab - 40 Pa ) 
4.2. Radiation protection instrurnents 
In the cyclotron vault, the hot lab and the serni hot lab a Geiger Müller counter was installed for 
radiation surveillance. The rnesurernent systern in the vault is used for the vault door interlock. If the 
value is too high, the door cannot be opened. The normal value is about 1 rnSvlh, during the 
bornbardrnent the value is about 9 rnSvlh at fluorine production. The other Systems in the 
radiochernistry are not used for interlock. 
4.3 Liquid waste systern 
The liquid waste systern is very simple due to the short half - lives of the produced 
radiopharrnaceuticals. 
Two tanks are available with a cornplete volurne of 2000 1. Every two weeks we have to unload the 
tanks after controlling a sarnple of 20 1 of the waste water. 
4.4 Cornpressor systern 
The cornpressor systern existing of two redundant systerns is used for the waste gases produced by 
the synthesis. We are able to cornpress the gases into two tanks with a volurne of together 400 1 both at 
6 bar. 
4.5 Monitoring of radiation in ventilation 
3 places for rnesurernent systerns 
Cyclotron value too high: the ion source stops ( or can not be started ), the vault is closed 
by special valves in the ventilation systern, and the air condition is 
stopped for the cyclotron vault and the roorn nearby 
Hotcells value too high: the valves of the ventilation of the hotcells are closed 
Chirnney this place (near the end of the chirnney ) was used only for the 
docurnentation of the values (gerrnan radiation protection prescription) 
5. Address 
Herz- und Diabeteszentrum NRW 
Institut für molekulare Biophysik, Radiopharmazie und Nuklearmedizin 
Georgstraße 11 
32545 Bad Oeynhausen 
Director 
PD Dr.rned.Dipl.Phys. Gunawan Notoharniprodjo Tel. 05731 - 971865 
Cyclotron 
Dipl. Ing. Petra Gerken 
Dipl. ing. Reiner Weise 
Chernistry 
Dr. Sytse Zijlstra 
Diplhg. Rüdiger Wortrnann 
FAX Nurnber of the Institute 
Tel. 05731 - 971 85411 876 
Tel. 05731 - 971843 
Tel. 05731 - 971855 
Tel. 05731 - 971 854 
THE GENEVA PET PROJECT 
G.J. BEYER, A. DONATH, C. MOREL, C. VACHEY 
Division of Nuclear Medicine, Geneva University Hospital 
CH-1211 Geneva 4, Switzerland 
Abstract 
The Geneva PET project started in the early 80s with the construction of a rotating PET camera made 
of two large area avalanche chambers. Then a prototype BGO-based rotating positron tomograph 
(PRT-1) became operational in 1991, followed in 1995 by the acquisition of the commercial ECAT ART 
System. The decision to develop a fully equipped PET centre in Geneva with a cyclotron and a 
radiopharmaceutical production unit was made in 1992. In this presentation we will Cover the most 
important points that have motivated our choices for cyclotron and laboratory layout. An IBA Cyclone 
1819 has been ordered and manufactured. The construction of the vault will Start at the end of this year 
and the equipment will be delivered within about one year from now. 
1. Background of the Geneva PET project 
The Geneva University Hospital played an important role with D. Townsend in the development of a 
new generation of cost-effective PET Scanners. In 1983, D. Townsend et al. developed a rotating PET 
camera comprising two large area gas detectors: the HIDAC cameral. It has been extensively used 
until the late 80s for human thyroid studies with 1241. Very similar detectors developed in Rossendorf 
by ~ a n f r a s s ~  et al. initiated the Rossendorf PET program as well. 
Since the overall efficiency of such gas detectors for 51 1 keV is rather poor, D. Townsend et al., 
together with industry, started to develop a new type of rotating PET camera based on BGO detector 
blocks. As a result of this, a prototype rotating tomograph using standard CTI BGO detector blocks, the 
PRT-1 camera3, became operational in 1991, and a second prototype also developed by D. 
Townsend et al., the PRT-2 camera4, has been installed last year at the Paul Scherrer Institute (PSI) in 
Villigen. PRT-I was used for clinical routine application with [18~fluorodeoxyglucose (FDG) shipped to 
Geneva from Lyon and PSI. Finally, late 1993 the Republic and Canton of Geneva voted a law to 
provide Geneva with a fully equipped PET centre comprising a cyclotron and a radiopharmaceutical 
production unit. 
2. Guide lines for the Geneva PET project 
2.1 General remarks 
Based on a tradition of many years of research and development at the Geneva University Hospital, the 
future Geneva PET centre is designed to fulfil clinical routine and research missions. Clinical routine 
and research will rely on standard positron-emitting radb-pharmaceuticaic, whereas more fundamental 
research on PET radiochemistry and instrumentation, as well as scientific training and teaching will be 
made possible. As an example, equipment setup will allow to think of operating production 
technologies for medium Z positron emitters. These requirements have cleariy motivated the choice of 
the cyclotron which is going to be installed in Geneva, the IBA Cyclone 18/9, and have guided the 
design of the cyclotron vault that will allow to build an extemal beam line. 
The guidelines listed below were taken into account to design the laboratory layout of the radio- 
pharmaceutical production unit. 
i Radiation protection rules: 
- radiation shielding, 
- radiation dose monitoring, 
- radiation interference limits with atmosphere and water; 
ii Pharmaceutical production rules: 
- phannaiaws, 
- good manufacturing practice (GMP) and good laboratory practice (GLP), 
- quality insurance. 
2.2 Radiation protection 
Due to space constraints, the cyclotron vault will be equipped with a heavy concrete air-lifted French 
door. The thickness of the vault and of the door will be 2 rn of 2.35 g/cm3 concrete, so that dose rates 
outside the vault will stay below 100 pSvIh. 
lnterference lirnits in the exhaust air of 200 6q/rn3 averaged over one year need to be rnet. To fulfil this 
lirnit, air change in the cyclotron vault will be diminished frorn 10 fold air change when there is no beam 
to less than 3 fold air change in presence of bearn. Air will be continuously pumped out of the vault to 
monitor its dose rate. lncoming air will be stopped and the cyclotron turned off each time the rneasured 
dose rate exceeds a given threshold value. 
About 10 to 20 fold air change will be maintained in the laboratories, following a recomrnendation for 
keeping a class D certification for clean room conditions. High attention is paid to the design of the hot 
cells, as for as interference and radiation protection are concerned. They must be tight and rnust 
continuously stay depressed. Moreover, they must be ventilated with a diagonal air flow, even when air 
change is drastically diminished. Cells will be run below 1 fold air change when synthesis is periormed. 
The whole radiopharrnaceutical production unit, including the cyclotron vault and its related areas will 
represent a class B laboratory and be a single controlled area according to the Swiss regulation on 
radioprotection. 
2.2 Radiopharmaceutical production 
We expect that in the near future: 
- short-lived radio-pharmaceuticals will have to be handled like pharrnaceuticals, 
- different persons will be responsible for production and for application, 
- in-house delivering of an in-house produced radiopharmaceutical will have to cornply with 
distribution rules to a third patiy. 
Moreover, we will need special authorications from: 
- the Swiss authorities to operate the installation for producing short-lived PET radio- 
pharmaceuticals, 
- the Republic and Canton of Geneva to exploit in-house produced PET radio-pharmaceuticals. 
Laboratory layout must be designed to meet the requirements for pharmaceutical production as close 
as possible. This irnplies to fulfil at least D class clean roorn conditions where dust sources need to be 
avoided, providing that synthesis of pharmaceuticals will be carried out under aseptic conditions. 
Cornmercially available rnodules for routine production of PET radiopharrnaceuticals, as well as 
equipment for quality control and quality insurance, will be selected according to the requirements 
mentioned above. 
3. The Geneva PET laboratory 
The PET radiopharmaceutical production unit will be located between the entrance of the hospital and 
the building where the division of nuclear medicine is located. Figure 1 shows the layout of the site. 
The cyclotron vault and the hot laboratory, as well as a technical room and a small workshop, will be 
located in a new building, whereas the chemistry and quality control laboratories, the control roorn and 
the entering sluice with its decontamination shower, as well as a rneeting room out of the controlled 
area, will be three floors below the division of nuclear medicine, in the Same building. For details, See 
Figure 1 and Table 1. 
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Table 1 : Technical specifications for the Geneva PET project 
Seneral aspects: 
Cyclotron: IBA Cyclone 1819. 
Cyclotron vault: 2 m of 2.35 g/cm3 concrete. 
Access to cyclotron: 2 m thick air-lifted French door. 
?lassifica tion: 
Clean room conditions: class D laboratory. 
Radiation protection: class B laboratoty in a single controlled area, 
entrance through a sluice with a chicane and a decontarnination 
shower, 
emergency exit not accessible frorn outside the controlled area. 
-aboratories lying inside the controlled area: 
Control roorn: 25 m2, cyclotron and radiation control roorn, electronic workshop, 
Passage to other rooms of the controlled area. 
Hot laboratory: 50 m2, 3 hot cells and 6 minicells, 2 laboratory hoods for isotope 
work, dispensing unit, computer, other equipment. 
Quality control laboratory: 36 m2, quality control equipment, other equiprnent. 
Chernistry laboratory: 24 m2, 2 laboratory hoods, glass washing machine, sterile water 
producer, other standard laboratoty equiprnent. 
Technical room: 20 m2, RF and control electronics for the cyclotron. 
Workshop: 15 m2, drill, millingcutter, lathe. 
Conditioning room: 8 m2, for packing and shipping. 
Safety corridor: access to the emergency exit, belongs to the hot laboratoty. 
Cyclotron corridor: access to the cyclotron. 
boms lying outside the controlled area: 
Technique: 80 m2, ventilation. 
Gases: 15 m2, Open air shelter for gas bottles. 
Meeting roorn: 25 m2. 
Toilette: near entrance of the controlled area. 
Staff 
Physics 
Christian MOREL, Ph.D. 
Division de Medecine Nucleaire 
tel.: 141 22 37 27 151 
fax: +41 22 37 27 169 
email: christian.rnorel@ipn.unil.ch 
Nuclear medicine 
Prof. Alfred DONATH, M.D. 
Division de Medecine Nucleaire 
tel.: +41 22 37 27 141 
fax: +41 22 37 27 177 
email: donath-alfredQdiogenes.hcuge.ch 
Chemistry 
Prof. Gerd Jurgend BEYER, Ph.D. 
Division de Medecine Nucleaire 
tel.: +41 22 37 27 165 
fax: +41 37 27 169 
email: gerd.beyerQcem.ch 
Hospital project direction 
Christophe VACHEY 
Direction, service etudes et developpernent 
tel.: +41 22 37 26 022 
fax: +41 22 37 26 020 
ernail: vachey-christopheQdiogenes.hcuge.ch 
Figure 1 : Layout of the radiopharmaceutical production unit of the Geneva PET project 
SHORT PRESENTATION OF IBA 
Ion Beam Applications (IBA), a Belgian medium-sized company, is a spin-off of the Cyclotron 
Research Center of the University of Louvain (UCL) and of the National Institute for 
Radioelements (IRE), both leading institutions in particle accelerator development and operation. 
Founded in 1986, IBA employs now a personnel of 85 and has a yearly turnover of about 20 M 
USD. 
IBA builds its success on innovative products. At the roots of its foundation lays the design and 
development of a new type of compact cyclotron, the CYCLONE 30. This revolutionary system, 
specifically designed for industrial-scale production of radioisotopes has rapidly made the 
company a recognized leader in particle accelerators for medicine and industry. 
Applying the innovative principles of the CYCLONE 30 to smaller models, IBA has created, for 
hospital operation, a range of radioisotope production systems based on ultra-compact, low- 
energy, cyclotrons. These systems are dedicated to Positron Emission Tomography (PET), one of 
the most advanced techniques in medical imaging. 
The experience gained from the design of the low and medium energy cyclotrons was carried over 
to the development of higher energy cyclotrons from 70 to 235 MeV for radioisotpe production and 
radiation therapy applications. In the field of proton therapy, IBA has developed a cyclotron-based 
in-hospital systern equipped with isocentric gantries. The treatment capacity of such equipment is 
in the 20.000-30.000 sessions range per year. It allows a much larger number of Cancer patients 
to benefit from the very high precision of proton beam therapy. 
In the field of sterilisation and industnal ionisation, IBA manufactures and markets the 
RHODOTRON. It is a new breed of high powerlhigh energy electron accelerators based on the 
beam recirculating principle. RHODOTRON produces, at low energy consumption, a continuous 
beam of up to 250 kW power and energy range from 3 to 10 MeV. Such performances allow 
controlled treatment of a large number of products at on-line production speed under non-sterile 
conditions. 
IBA also develops customised systems such as the CYCLONE 18+, a compact cyclotron with 
beam intensiv in the 1,5 mA range, replacing nuclear reactors for producing palladium-103, a 
radioisotope used in brachytherapy. 
Summarv of manufactured accelerators 
CYCLONE 30 
Cyclotron acknowledged as the ideal equipment for industrial-scale production of most radioisotopes 
used in nuclear medicine. Accelerating negative ions, CYCLONE 30 produces reliable, high-intensiv, 
extracted beam in the 350-700 microamps range with a level of productivity nearing 100%. Its energy 
conversion efficiency is over 15%: 15 kW of extracted beam for less than 100 kW power consumption 
The systern allows simultaneous extraction of two beams. Fully automated, of straightforward design it 
allows for quick and easy maintenance. It is worth noticing that today, all industrial producers of 
radiopharmaceuticals operate one or two CYCLONE 30 cyclotrons. 
~ 
Compact PET-dedicated cyclotrons to Cover all needs of PET radionuclide production: 
Cyclone 1819 
Accelerating protons up to 18 MeV and deuterons up to 9 MeV, CYCLONE 1819 has been designed for 
large scale production of PET compounds. Having inherited the innovative features of CYLCONE 30, 
CYCLONE 1819 accelerates negatively charged ions with an extraction efficiency nearing 100 %. 
Especially compact, considering its power and capacity, the System can be equipped with 8 targets 
and can simultaneously produce two radioisotopes. Because of its high level of productivity and its 
flexibility, Cyclone 1819 is ideally matched to the requirements of PET distribution centres, large 
hospitals and research institutions. 
CYCLONE 1015 
A small version of CYCLONE 1819, CYCLONE 1015 (10 MeV proton, 5 MeV deuterons) carries the 
innovative features of larger accelerators: acceleration of negative ions, 8 targets, simultaneous 
extraction of two radioisotopes, complete reliability and high production yields. It is the cost-effective 
solution for producing all PET radioisotopes. It can be installed with self-shielding. 
CYCLONE 3
It is a 150 generator providing a steady supply of 4 important radiolabelled compounds: 150„ C150, 
CI5O, and H,'50. Probably the smallest commercial cyclotron available, it is designed for easy 
installation at virtually any site. CYCLONE 3 is particularly useful for medical centres which specialise in 
diagnostic procedures employing 150 or which collaborate with distribution centres producing F-18 
compounds. 
PROTONTHERAPY 
Applying here again the innovative principles of CYCLONE 30, IBA was the first to put forward the 
concept of a marketable, turnkey, proton therapy centre designed for in-hospital operation. 
The IBA profon fherapy sysfem is based on a compacf, high energy 235 MeV cyclofron providing 
beams to 4 freatmenf rooms allowing over 20,000 sessions per year. This corresponds to the full 
freatmenf of more fhan 1,000 pafienfs. Some treatment rooms are equipped with isocentric gantries 
which rotate around the patient allowing the tumour to be irradiated, with very high precision, from the 
most favourable angles. Other treatment rooms, equipped with stationary beam Systems, vertical or 
horizontal, are reserved for specific cases and for research applications. Proton beam radiotherapy is a 
technologically advanced means of achieving precise radiation dose distribution. 
CYCLONE 18+ 
At first, experts rated its exceptional performances as "impossible". Its beam current of more fhan one 
milliampere amounts to five times more than the current capability of a standard cyclotron. It allows 
production, in a cost-effective way, of palladium 103 by using rhodium, a commonplace metal. Until 
CYCLONE 18+ started operation, palladium 103 could only be produced by nuclear reactors. Palladium 
103 is a radioisotope used by implants, in the treatment of certain type of cancer, especially prostate 
cancer. IBA's remarquable performance was accomplished in record time. From design of the new 
machine to start-up at customer's site, the whole project was carried out within the incredibly short 
period of 12 months. 
RODHOTRON 
The Rhodotron's innovative design is based on the beam recirculating principle where the 
electrons are recirculated throughout a single cavity by using several deflecting magnets. 
This unique design is a departure from classical electron beam techniques and limitations 
where electrons are accelerated through a succession of cavities along a linear path. 
Marketed in several models with an energy range from I to 10 MeV combined with a power 
range from 35 kW to 250 kW, the Rhodotron family of accelerators provides a superior level 
of reliability, flexibility and operational economy. It can meet the most strenuous of industrial 
demands. Additional benefits include compactness and lower building costs as well as fast, 
easy maintenance. 
IBA has continuously up-graded its accelerator Systems to improve their reliability and performance. 
This upgrade program includes: 
1. Redesign of the central region, the deelcavity structure and the ion sources to maximize 
beam current stability and output. 
The Cyclone 1819 has a "deep valleyn magnet design. The sources, one producing H- ions the other 
producing D- ions, are located in two opposite valleys. Their insertion mode is radial. The dees are 
located in the valleys that do not contain a source. The dees are connected at the center and supported 
On one side by vertical copper stems. 
On the three first CYCLONE 1819 (Montreal, Shreveport and Rossendorf machines), these stems are 
fixed to the upper part of the yoke. Therefore, central region and source adjustments have to be carried 
out after each opening and closing of the cyclotron, by means of radial and azimutal movements. 
From the fourth machine, the stems are fixed to the lower part of the yoke and then, the sources and 
the central region can be adjusted with the cyclotron opened. The source movements have been 
suppressed and the sources are now stabilized and Set in their optimal position. This redesign avoids 
any tuning or uncertainty about the source position, and accidental burning of the source chimneys. 
2. A relocalization of the targets, improving beam transmission and target shielding. 
Targets are now directly mounted on the vacuum chamber, rather than On short external beam lines. 
Access to the targets is always possible without lifting the upper yoke. 
This new location improves the beam extraction yield: as an illustration, the proton beam transmission 
yield is now about 80 to 100%, through a collimator of 10 mm in diameter, (instead of 50-60%, 
previously). 
Better extraction efficiency allows to reduce accelerated beam intensity, providing several benefits: 
- reduction of the source gas fiow and then improvement of the internal beam transmission, 
- reduction of loss in the machine and of the activation in the machine, 
- increase of the lifetime of consumable such as cathodes and chimneys. 
Table 1 
I I Beam on I Beam on I Extract" ( Beam on I TransmissO ( Source Source Arc ) 
The eight targets are located in the mid-plane all around the vacuum chamber and are partially shielded 
by the yoke. An Operator working on any target is thus able to be at the maximum distance from other 
possibly activated targets. 
Optional shielded doors can also be mounted in front of each target in order to reduce the radioactivity 
level. As an example, on one of our Cyclone 1819 machines installed at the Hementrum Nordrhein- 
Westfalen in Bad Oeynhausen, each target is self-shielded with a steel door, 10 cm thick, reducing the 
radioactive dose rate by a factor 4. 
New design 
Old design 
Target 
15 pA 
15 pA 
Stripper 
17 pA 
25 pA 
Yield 
90 % 
60 % 
Pop- Up 
21 pA 
35 pA 
Yield 
80 % 
70 % 
Gas Flow 
2 ccimin 
3 cdmin 
lntensity 
0.1 A 
0.2 A 
3. Pneumatic gate valve on target. 
In the case of internal target configuration (see point 2), pneumatic gate valves have been designed to 
be installed between the vacuum chamber and each target (implernented on Geneva and Hadassah 
machines). Maintenance on target, window holder and collimator can be performed without interrupting 
the vacuurn in the cyclotron. 
4. Pressure transducer inside the target. 
The Cyclone 1819 from Geneva is rnounted with pressure transducers inside the targets, allowing the 
internal pressure to be measured and thus preventing window foil rupture. This is specifically helpful for 
the F2, C-1 1 and F-1 8 targets. 
5. F-18 large volume target 
For high F-18 production, IBA has designed a large volume target of 1.5 ml (installed on Pamplona 
rnachine). This target allows to produce rnore than 3 Ci of F-18 in two hours, with 18 MeV protons. 
More than 6 Ci of F-18 can be achieved in dual beam mode, in irradiating simultaneously two F-18 
targets. 
6. Source gas control 
For an easier optimization of the beam transmission yield inside the rnachine, the source gas flowrneter 
could optionally be controlled frorn the control system. 
7. The ongoing development of the software. 
Soitware is continuously improved for better access to the main Parameters and easier operation of the 
system. A logbook of cyclotron operation can be provided as weil as a data log which records the main 
data of the system. These records can be easily transferred to a spreadsheet table for analysis. For 
example, the integrated beam current of each particle (protons or deuterons) is recorded to keep track 
of the lifetime of the cathodes of the ion sources. The Same measurernent is done for each stripper foil. 
These records are very useful for planning and scheduling preventive maintenance. The Programrnable 
Logic Controller can accomodate signals corning from other equipment, such as Rags from the stack 
rnonitors or area radiation rnonitors to be used as safety interlocks. 
A new display representing vacuum level versus time is very helpful to detect a vacuum leak. 
Fig. 1 : Central Flowchart for the Control of the PET System 
8. Maintenance 
For more efficient maintenance, a special effort has been made on providing quick release connections 
for water, electrical and gas tubing to allow an easy and rapid dismount of each part of the cyclotron 
su b-systems. 
9. Customized system 
An external beam transport line has been specially designed on the Cyclone 1819 for 
Forschungszentrum Rossendori, to enable it to be used for target development and education 
purposes. The transmission yields are higher than 50% through a collimator of 12 mm diameter. The 
beam spot diameter is approximately 15 mm, without hot spot. Beam current instabilities are less than 
5%. 
Fig. 2 : External transport beam line 
Conclusion: 
The main aim of these improvements has been to increase reliability and the radioisotopes production 
yields, whilst, at the Same time, reducing the activation in the machine and providing an increase in the 
Iifetime of consumable such as source chimney and cathodes. 
The table 2, hereafter, recapitulates the production yields obtained during the installation of the Cyclone 
1819 at Pamplona, the latest installed machine. 
Target pressure transducers (item 4), source gas control (item 6), software modification (item 7) could 
easily be retrofitted on all the Cyclone 1819 machines. Interna1 location of the targets (items 2 and 3) 
and the up grade of the RF system (item 1) i.e. to replace the dee stems in the lower yoke, would be a 
major retrofit requiring large modifications to the machine. 
Table 2 
Recovered Activity 
4.058 mCi EOB 
3.372 mCi EOB 
370 mCi EOB 
500 mCi EOB 
980 mCi EOS 
540 mCi1min 
167 mCilmin 
544 mCilmin 
Isotopes 
C-I I 
F-I 8 
F-I 8 
N-13 
0-15 
0-1 5 
0-1 5 
Beam Current on 
Target 
45 pA 
22 FA 
25 pA 
20 pA 
30 HA 
20 pA 
20 pA 
Chemical Form 
Co2 
F- 
F2 
NH3 
H20 
0 2  
CO 
Irradiation 
Time 
30 min 
120 min 
60 min 
20 min 
10 min 
on line 
on line 
on line 0-1 5 CO2 I 20 pA 
THE IBA CUSTOMER SERVICE 
The IBA Customer Service Section is part of the Technical Department, which is supervised by Mr. 
Jean-Louis Bol, Technical Director and Mr. Claude Dupont, Technical Department Deputy Manager. 
Mrs Charline Englebert, the Administrative Assistant in the Customer Service, is the contact in the first 
instance for all follow up and day-today requests as information, quotations, orders, technical supports, 
urgent intervention.. . 
She will forward the requestlcall to the most appropriate person/specialist. 
Mr David Clark will answer all commercial matters and finalise all quotations. 
Their contact telephone numbers are the following: 
Mrs Charline Englebert 
Administrative Assistant Customer Service 
Mr David Clark 
Area Sales Manager 
I5A Reception Desk 
/BA Fax Machine 
Mrs Charline Englebert Fax Machine 
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2. NORTH AMERICA 
Massachusetts General. Hospital 
DuPont Merck Pharmaceutical 
Mallinckrodt Medical 
Medi-Physics Inc. 
VA - SUNY at Buffalo 
Biomedical Research Foundation 
McGill University, Neurological Inst. 
Theragenics Corporation 
Theragenics Corporation 
Theragenics Corporation 
Theragenics Corporation 
IPEN (Institut0 de Pesquisas 
Energeticas e Nucleares) 
Medolla, I 
Mortsel, B 
Madrid, E 
MA, USA 
MA, USA 
MO, USA 
NJ, USA 
NY, USA 
Shreveport, LA, USA 
Montreal, Canada 
GA, USA 
GA. USA 
GA, USA 
GA. USA 
Sao Paulo, Brazil 
CYCLONE 30 + PET 
CYCLONE 1819 + PET 
CYCLONE 1819 + PET 
F-18 PET Target 
FDG MODULE 
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4. ASIA - OCEANIA - MIDDLE EAST 
Shanghai Inst. of Nuclear Research 
China Institute of Atomic Energy 
Daiichi Radioisotope Labs 
Nihon Medi-Physics 
Nihon Medi-Physics 
Atomic Energy Organization 
Atomic Energy Organization 
Hadassah Medical Centers 
ANSTO 
(Australian National Science & 
Technology Organization) 
Austin Hospital 
Badan Tenaga Atom Nasional 
Shanghai, China 
Pekin, China 
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Hyogo, Japan 
Hyogo, Japan 
Tehran, lran 
Tehran, lran 
Jerusalern, Israel 
Sydney, Australia 
Melbourne, Australia 
Jakarta, Indonesia 
CYCLONE 30 + FDG 
CYCLONE 1819 + PET 
CYCLONE 30 + PET 
1 BEAM LINE 
1 SOLID TARGET 
CYCLONE 1015 + PET 
Cyclotron Conversion 
THE PETICYCLOTRON CENTER OF THE HUMAN BIOLOGY 
RESEARCH CENTER (HBRC) AT HADASSAH HEBREW UNlVERSlTY 
HOSPITAL (JERUSALEM, ISRAEL) 
ROLAND CHISIN, MD, YONA MAHLER, Ph.D., NAHUM LIFSHITZ, Eng. 
A PETICyclotron Center (as part of the HBRC) is erected on the Ein Kerem campus of .Hadassah 
Hebrew University Hospital in Jerusalem (Israel). The current PET camera is a Posicam HZL imager 
from Positron Corporation (Houston, Texas) and will be exchanged for a 'G.E.' Advance system in 
spring of next year (1997). This Center is operated by the Department of Medical Biophysics and 
Nuclear Medicine and the Department of Medical Engineering and Instrumentation Division. This 
PET Laboratory is devoted to research, including clinical research. Up to the end of August 1996. 
280 PET heart scans have been performed using Rubidium generaton imported from the U.S. The 
cyclotron should be operational in Febniary 1997 and FDG-PET scans done in a fint Stage. 
~ h e  PET suite located in Nuclear Medicine is composed of 2 rooms for PET imagers, a hot 
laboratory used in particular for blood sample radioactivity counting, an ancillary cold laboratory and 
an evaluation room with workstations networked with the PET camera and the SPECT machines of 
the Department of Nuclear Medicine. 
The Cyclotron is housed in a three-level building located in an excavation site. One level is 
occupied by the cyclotron, the hot and cold radiochemistry laboratones, one level below wntains 
mainly the various pipes and one level above houses the air conditioning system. 
The targets which will be used are: F-1 8. C-1 1, N-13. 0-15 and 18-F-2 targets. 
The ordered modules comprise an 'IBA' FDG automated system and a [I 1CJ-methylation 'Nuclear 
Interface' system as well as other IBA modules housed in 6 'ComeceP cabinets. In addition. there 
will be Wo big hot cells for research works. 
We have hired the services of the Rotem Company (Nahal Soreq, Israel) which has designed and 
sold us a safety network of detectors placed along the air wnditioning system, drainage routes and 
all over the cyclotron area. 
Diredor of PETlCyclotron Center: 
Roland Chisin, MD 
Tel: 972-2-6776705; 972-2-6439575 
e-rnail: chisin@md2.huji.ac.iI 
fax: 972-2-6421 203 
Cyclotron Engineer 
Nahum Lifshits 
Tel: 972-2-6777058 
Radiochernist: 
Dr. Eyal Mishani (see R. Chisin) 

The CYCLONE 1819 at MN1 
Dean Jolly 
lntroduction 
The radiochemistry - cyclotron unit is a "service provider" developing and producing 
tracers, mainly on  a collaborative basis, for the scientists a t  MNI. 
A t  the present time, the fol lowing tracers are available : 
150  - gases 
150  H,O 
'C - alphamethyl tryptophan 
C - Benztropine 
'C - Deprenyl 
' C - Flumazenyl 
" C - P K  11195 
C - Raclopride 
"C - SCH 23390 
''F - FDG 
''F - FDOPA 
18F- 3 Ornethyl FDOPA 
Layout of the facility 
The cyclotron arrived in Montreal in August o f  1992 and after many months o f  work it 
became operational. 
It was installed in  a pre-existing setup comprising of a vault, t o  house the cyclotron, one hot 
lab, one cold lab, a power supply room and a control room. 
The facility is undergoing renovations to  increase the work space by  building t w o  new  
offices, a larger chemical stock room and t w o  n e w  labs. 
Description of the cyclotron 
The CYCLONE 1819 at MN1 was one of the f irst o f  i ts kind built. 
This means that the DEES are suspended w i th  pillars from the top yoke and the ion sources 
are fully adjustable f rom outside the vacuum chamber. 
Five of the eight exits are being used , three for H+and  two  for D + .  
Targetry 
Because of the wide scope o f  interests a t  MN1 there are targets t o  produce all the common 
PET isotopes. 
EXlT # 
1 
table 1 : Cyclotron tarsets 
TARGET MANUFACTURER 
18F-F, ( 180- 0, gas 1 CTI 
not  used 
not  used 
150  gases 
not  used 
C gases 
Depending on  the study and isotope, varying beam intensities are used. They range f rom 2 
to  12 uA  for D- and 10 t o  20 u A  for H-. 
table 2 : l s o t o ~ e  ~ roduc t i on  
l s o t o ~ e  Mode Beam Bombardment time Yield 
U A min mCi 
150- H20 batch 3 
"C -CO2 batch 20 
1 8 ~ -  F2 batch 12 
( F,/Ne 1 
Cyclotron Operation and Maintenance 
The cyclotron operates reasonably well, w i th  a heavy demand ( three days ou t  of  six; 
eight to  twelve hours l  day ) for 150 - H20. 
Because of this, the D- source requires maintenance every six to eight weeks ( new 
cathodes every second rnaintenance and t w o  to  three chimneys a year ). 
On the other hand, the H- source is only cleaned every six months. 
The other rnajor problem is that after using a silver target 12  to 1 5  times, it stans releasing 
silver and thus causes poor yields of FDG due t o  meta1 poisoning o f  the kryptofix 
potassium complex. 
table 3 : T v ~ i c a l  O~e ra t i na  Darameters 
Parameter 
Base Vacuurn 
I.S. gas on 
Port 
Particle 
Magnet voltage 
current 
RF Voltage 
incident power  
refelcted power  
Ion Source Voltage 
Current 
Stripper position 
Bearn Currents 
- Stripper 
- Collimator 
- Target 
-% TgtIStr 
Chemistry Modules 
There are three commercially available chemistry modules on site and one designed and built 
at MNI. 
A 'C - CH31 black box from Scanditronix producing routinely over 1 Ci of CH31, 
and from CTI t w o  CPCUs, one for FDG ( 5 0  % yield ) and one for FDOPA ( still testing ).  
The module designed and built at MN1 is a simple module utilizing a l ow  cost robot that does 
all the 'C  syntheses. It has undergone several months of testing, without a single 
downtime since its construction in June 1996. 
A t  present it is used to  make , on a routine basis, Benztropine.Depreny1, PK 11  195  and 
SCH 23390. 
Address 
Cyclotron facility 
Montreal Neurological Institute 
3801  University 
Montreal, Ouebec 
Canada 
H3 2 8 4  
Telephone 
lab : 51  4 3 9 8  - 8527  
fax : 5 1 4  3 9 8  - 8 1  95 
Staff 
Director : Dr Mirko Diksic 
EMail - Mirko@PET.MNI.MCGILL.CA 
Cyclotron operator : Edward Errington 
Chemist 1 Cyclotron operator : Dean Jolly 
EMail - DEANJ@BIC.MNI.MCGILL.CA 
Chemist : Donald Porter 
EMail - Do~@BIC.MNI.MCGILL.CA 
Research Associate : Dr Shadrek Mzengeza 
EMail - SHADRECK@BIC.MNI.MCGILL.CA 
PET-CUN CENTER 
University Hospital of Navarra School of Medicine 
Pamplona. Spain 
JM MartC-Climent, I Petiuelas, JA Richter 
1. Aims of the institute 
The University Clinic is a General Hospital with interest in the clinical and research applications of 
PET: neurology, cardiology and oncology. 
Only ten months were elapsed from the signature of the contract until the end of the acceptance tests 
for the cyclotron. The final approval of the installation from the Nuclear Security Council was received 
in July 1996. 
2. PET center 
The PET CUN center is constituted by a Cyclone 1819 cyclotron, a high recolution PET scanner 
(ECAT EXACT HR+, Siemens) and a radiochemistry laboratyy. The layout of the center is shown in 
figure 1. The total surface of the PET facility is around 400 m . 
Figure 1: General representation of the PET CUN center facilities. The numbers indicate the 
follawing areas: 1) Cyclotron vault. 2) Technical room (gas supply cabinets, cooling system ...) 3) 
Technical room (power supply, electronics ...) 4) Control room (ventilation system and cyclotron) 5) 
Decontamination area. 6) Hot laboratory -6a. hot cells for autornatic synthesis modules, 6b. hot cells 
for dose preparation and shielded laminar flow hood-. 7) Quality control laboratory. 8) Blood 
laboratory. 9) PET scanner control room. 10) PET scanner room. 11) Patient preparation area. 
The cydotron is equipped with five targets, for the production of, "C, 1 3 ~ ,  150, "F* and "F (large 
volume). The location of the targets in the cyclotron is shawn in table 1. Result of the acceptance 
tests are s h m  in taue 2. 
Table 1: Targetry 
Table 2: Cydotron produdion: Acceptallce tesi results 
I I Time (min) I I I mCi I 
2 2  Chemistry modules 
The PET CUN Center facility is equipped with a very compiete radiochemistry (table 3). 
Table 3: Radiodiemistty modules 
Moduk t Suppthw I Status 
F m 1  I Nudear Interface I Operating daily 
1 FüG-2 with water recovew unit 1 I I - - I BA I lnstalled I 
1 Methvlaüon unit 1 Nudear Interface 1 lnstalled I 
I 1 
ilic and elecbophilic I Nudear Interface I Not installed yet ( 
su~tution unit 1 I 
Gas module IBA lnstalled I 
Only the FDG module from Nudear Interface is fully operative, and more than 50 FDG synthesis 
have been carried out with it, with very good yields. The FDG module from IBA hss only been used 
three times unül W .  
The arnonia stand and the Wer module have been wed several tirnes, mainly for experirnents and 
not for patients, with quite good produdion rates (table 4). Nonetheless, five H2150 studies have 
already been canied out. 
Table 4: Saturation yields for tim different compounds 
2.3 Time of operation 
The cydotron is operated daily. from monday to friday, an average time of 1 hour pe; q 3 f o r  the 
p u d i o n  y i  "F in the m i n g  and some days it is also operated for the pmdudion of G. NHi or 
C&. The F2 target has only been used in the acceptance tests. The operating conditions for each 
one of the targets, along with the obtained yieids are summarised in table 5. 
Table 5: Operational conditions of the cyciotron 
2.4 Safety and security measures 
Target/compound 
18F 
I3~t-4  
~ ~ ' ~ 0  
Several safety interiocks have been installed for the safeguarded Operation of the cyciotron and to 
avoid any kind of accident when transfening the activity from the target to the hot cells. 
The signals amving to the cydotron are the fdlowing: 
1. Ernergency stop signals coming from the hot lab, inside the vauk the technical rooms and 
thecontrolroom 
2. The irradiaüon is a l l d  only if the fdlowing conditions are satisfied: the cyciotron vault 
doof is dosed, there is no emergency signal in the cydotron vault door, the ventilation 
System is OK, and there is no fire signal 
3. The radiation Wels inside the vault are below 200 pSv/h 
4. The imi cdls are dosed. This is used when transferring materials from the cyclotron. 
5. Unabie to send gases to the PET Scanner room unless it is authorised from the PET area 
6. UnaMe to send target content to synthesis rnodules unless a ready signal comes from the 
moduie (only used with the Nudear Interface modules) 
Time of inadiaäon 
(min) 
60 
10 
10
The output signals f m  the cydatron are: 
1. The magnetic fieid is on. A light is tumed on in the cydauwi contrd zone 
2. The beam is on. Light signals are tumed on in the cydotron vault room, hot laboratory, 
and technical rooms 
3. Cyclotron vault door opening is not allwed: 
During irradiation 
During 5 minutes after the end of the irradiation 
if the radiation inside the vault is greater than 200 pSv/h 
Current (M) 
17 
10 
10 
The cydotron vaun door has an emergency opening, acoustic and light signals when moving, and 
gets a signal from the cyciotron not allovuing it to be opened. 
Produdion GBq 
(ma) 
48.1 (1300) 
6.7 (180) 
10 (270) 
Different lead containers an? used to reduce the radiaüon levels wher~ handling radioactive mathals. 
The radiation detectom used in the PET center are: 
Gamma area monitor in the cydotron vault, with the display in the controi zone 
Neutron area rnonitor outside the cyclotron vault 
Gamma area monitor in the hot laboratory 
Portable survey gamma meter (ion chamber) 
Portable contamination detedor (pancake Geiger counter) 
Hands, feet and dothe contamination detedor 
Personal dosirneters: Whole bcdy and ring thermoiumineccence detectm, and dired reading 
dosirneters with acousüc alarm 
2.5 Environmental care 
A special ventilation system for the cyclotron vault, hot laboratory, hot cells and PET Scanner rwm is 
used (figure 2): 
It provides 10 air renovations per hour in each zone and 10 PA of underpressure. 
A gamma detector (1 "XI" Nal(T1)) is placed in each srnokestack in order to detect any release from 
its zone. If the release is over an authorised limit, it tums on a dilution system (from 2200 to 22000 
r n 3 ~ ) .  
Another detector (2"e Nal(T1)) is in the general srnokestack to detect if the final concentration 
(after dilution) is beim the operational limit (2.5 pSvih). When the release is not allowd, it closec 
the floodgate of the contaminated zone. 
Display of each detector is placed in the corresponding area in oder to show to the peopie working 
there the radiation levds of their arm. The radiation levels are also contrdled thmugh a personal 
Computer, where it is possibie to fdlow the reading of each detector. An alam signal is send to 
the ventilation system when the release is higher than the authorised levds. 
A themoluminescence detector is installed in the general srnokestack to integrate the dose released 
per month. 
Figure 2: Ventilation system. D: l"xlWNal(TI) detector, D2: 2"QNal(TI) detector. P: Input and output 
pressure reading of each zone. 
Centro PET. Servicio de Medicina Nuciear 
Clinica Universitaria de Navarra 
Avenida Pio MI d n  
31007 Pampiona, SPAlN 
Fax: 34 - 48 - 172294 
Tel: 34 - 48 - 296697 
e-mail: pnunezg@cun.unav.es 
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THE ROSSENDORF PET CYCLOTRON "CYCLONE 1819" FAClLlTY 
ST. PREUSCHE, F. FÜCHTNER, J. STEINBACH 
Forschungszentrum Rossendorf e. V., Institut für Bioanorganische und Radiopharmazeutische Chemie 
PF 51 01 19.0-01 314 Dresden, Germany 
1. lntroduction 
In the Rossendorf PET Center cooperate the Research Center Rossendorf Inc. and Dresden's University 
Hospital. It's scientific Programme is dedicated to fundamental radiochernical, radiopharrnaceutical, bio- 
rnedical research and clinical application. 
Our PET Center is equiped with the PET cyclotron "CYCLONE 1819 inclusive an external beam transpori 
line, radiochemical laboratories for research purposes and production of radiopharrnaceuticals according 
to GMP rules (Good Manufacturing Practice) and the Siemens PET camera ECAT EXACT HR (+). 
On grounds of local conditions the existing U-120 cyclotron building is also used for the CYCLONE 1819. 
The 500 rn distance to the radiopharmaceutical laboratories is bridged by our own developed radionuclide 
transport system. 
Present Status: All acceptance tests of the cyclotron and chemistry rnodules were fulfilled sucessfully at 
the end of February 1996 and the final check of the cyclotron facility by the TÜV organisation (TÜV = 
Association for Technical Inspection) were also done in that month. We anticipate the granting of the 
licence for routine operation of our PET cyclotron at the beginning of October 1996. 
2. Building 
The layout of the rooms is shown in Fig. 1. All of the roorns are located at cellar level. Wall thickness of 
the vault: 1.40 m - outer walls, 1.90 rn - sealing, 2.35 m - wall to control room. The hot lab (R001d) with 
box 0 (= hot cell) is the cyclotron-end terminal of the pneumatic post systern between cyclotron and 
radiochernistry building. 
During operation of the cyclotron the vault is closed with 2 doors. The door to roorn ROOl b is a sliding 
door filled with interlaced polyethylene bricks (thickness 16 cm). The rear is covered with cadrnium sheet 
rnetal. The door will be sealed airtight by an inflatable rubber tube which has to be filled with cornpressed 
air (low pressure inside the vault: - 50 Pa). The door to roorn ROOlc is filled with polyethylene plates 
(thickness 3 cm) and the rear is covered with 0.6 cm leadl,'. 
There are three ventilation systems for ventilation of activelnonactive roorns and hot cell 0 and additional 
one for venting the (N, + 0.5 % F,) gas valve and two systerns for rernoving flue gases in case of fire. 
All necessary gas bottles are placed inside closed racks outside the building. Cornpressed air (rnax. 6 
bar) is available in each roorn. 
3. Cyclotron, Targetry, Bearn Transport Line and Chernistry 
The cyclotron/chemistry rnodules can be controlled both with terminal 1 (cyclotron building) and terminal 
2 (radiochemistry building). Each of the terminals can be either the rnaster or the slave. Only the master 
terminal has the control of the cyclotron but all information is given on both screens. There is a special 
procedure for handing the control to the other terminal. 
At our cyclotron five IBA targets and a beam transpori line (BTL) are installed. We use the large volume 
target (1.5 ml) for [I8F]F-. The results of beam and yield acceptance tests are surnrnarized in Table 1. 
The Rossendorf chernistry modules ([18F]6-Fluoro-DOPA, ["CIMethyliodide), the Nuclear Interface 
chemistry module ([I8F]FDG) and the IBA chemistry modules ([150]H,0, [150]/11'C] gas processing, 
["CIHCN) are placed inside the hot cells 1 - 3 of the radiochemistry building (Fig. 2). 
The 2 rn long BTL at exit 2 is a special IBA development for Rossendorf. Target developrnent and use for 
PET in Rossendorf began in 1983. A vertical target changing device for 8 targets was built in 1990 and 
1s used now at the U-120 cyclotron for [llC]CO„ [l8F]F„ [18F]F- and [150]0, production and for solid 
targets. In 1997 we want to connect BTL and the vertical target changing device (then equiped with PLC 
control too). BTL is necessary for improvement of the reliability and availability of the targetry, future 
target development, production of other radionuclides and for training of technicians and radiochemists. 
To accept the BTL parameters only beam tests were carried out but with both particle types (Table 1). 
Table 1 : Results of bearn and chernistry tests 
Target for I "C I FZR targets 
Exit 
Particle 
Beam test 
- Collirnator / pA 
- Target / pA 55 25 
1 I 2 / BTL 
The rneasured instabilities of all bearn currents on targets during irradiation times were less than i 5 % 
and fulfilled our requirernents of bearn stability on target for production of radionuclides. The diameters of 
the bearn spot on a quartz at the end of BTL both for protons and deuterons were approximatly 15 rnrn 
and confirrned the IBA calculations. If required, it is possible to reach higher beam currents at exit 2. 
Dual bearns are possible at the exits 115 and 317. The results are given in Table 2. 
Chemistry test 
Activity at EOB / GBq 
- irradiation time / rnin 
- bearn on target / pA 
Table 2: Results of dual bearns 
> 74 
30 
34 
I Dual bearn at exit 1 1  5 1 3  7 1 
-- 
D- Particle 
Our radiochemistry/radiopharrnaceutical laboratories are equiped with nine hot cells (FZR, Waelischrnil- 
ler), several furne hoods, HPLC, GC, MC, TLC (BAS 2000), y-spectrometry, pH-meter and a LAL test for 
reseach purposes and production of radiopharmaceuticals including the qualiiy control. 
- 
H- 
Bearn on - Stripper / pA 
- Collirnator / pA 
- Target / pA 
4. - Radionuclide Transport a s t e m  (RATS) 
The 500 rn long RATS (Fig. 2) was designed to transport srnall volurnes of the irradiated liquids 
[180]H,~/[18F]F and H,0/[13N]NH3 with a pneurnatic post systern and the radioacüve gases within copper 
capillaries (ID: 1.5 mm) frorn the cyclotron to the radiochernistry laboratories. In the final layout of actiwty 
distribution the radiopharmaceutical laboratories of the nuclear rnedicine building will also be connected 
to the existing systern (Fig. 3). The pneurnatic post box systern consists of two polyethylene tubes (ID: 33 
mm, wall thickness: 8.4 rnm). The pneurnatic post box (length: 11 0 rnm) contains a vial. We use the sarne 
type of polyethylene tubes as second containrnent to protect the copper capillaries. Outside the cyclotron 
and radiochernistry building all polyethylene tubes lay 80 crn below ground level. 
The loading time of a pneurnatic post box is approxirnatly 2 rninutes and the transfer time for the 500 rn 
1 :30 rninutes (with 4 - 5 bar of cornpressed air). In rnore than 300 runs of pneurnatic post boxes the 
reliability of RATS was dernonstrated. For "C transport (EOB ==> BOS) we reached 4:30 rninutes W h  
26 bar of push gas. 
RATS is also controlled by 2 terrninals using the sarne rnaster-slave principle as in the control of the 
cyclotron. Both control systerns are coupled. Several interlock signals prevent the unloading process of 
a target if cyclotron or RATS is not ready for unloading3 
32.8 39.2 
14.5 21.0 
18.3 18.2 
5. Safety Aspects and Radiation Protection 
10.8 22.3 
1.0 11.7 
9.8 10.6 
Cyclotron: For personnel safety we installed an external interiock systern that swrtches off or 
disables the bearn, if one of the four cornponents is not in OK status: 
- emergency stop buttons in all rooms -sensors of the fire-alarm system in all rooms 
- STIlST2 door securii circuit (Fig.1) - pressure conditions in the vault: (-50 f 20) Pa. 
The radiation protection areas of the PET cyclotron are: 
without beam with beam 
controlled area: ROOI b, ROOI C, ROOl d ROOl d 
prohibited area: none ROOI b, ROOl C. 
An exhaust air emission measuring facility (Berthold) was installed for both the new PET cyclotron and 
the U-120 cyclotron to fulfil the demands of our authority. It contains of four main park: a gas monitor for 
continuous monitoring of radioactive gases with short half-life, a continuous aerosol collector with a con- 
stant flow of air, a transportable gas collector unit and an electronic system with switches for thresholds 
and a tot of possibilities for presentation of the measured values. A stationary dose rate meter (Berthold) 
with a GM tube and an ionisation chamber is installed inside the vault. The measured values are displayd 
in the control room, so that we have the knowledge of the radiation level inside the vault at any time. Both 
systems are not involved into the interlock system. 
RATS: Additional to the interlock system the loading unit of the pneumatic post system is 
equiped with a LASER Sensor to detect the right postion of the vial. The running time of the pneumatic 
post box is monitored too. 
Estimations of the possible exposure to radiation during transport of activiiy gave an additional doseiyear 
of 1 pSv (= 0.04 % of natural dose) for normal operation and 74  SV for worst case operation (pneuma- 
tic post box with 94 GBq of [18F]F-stay inside the transportation tube). 
6. 
3 .  
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BIOMEDICAL RESEARCH FOUNDATION 
PET IMAGING CENTER 
Description: 
The Biornedical Research Institute is a business oriented research facility, cornbining 
traditional acadernic research and private-sector initiatives for the developrnent and 
cornrnercialization of new discoveries. The Biornedical Research Foundation opened its first 
research Facility, the Biornedical Research Institute (BRI), in February of 1994. The BR1 is a 10 
story, 160,000 Square foot facility with 56 laboratories. The Louisiana State University School 
of Medicine in Shreveport occupies 48 of these laboratories to conduct biornedical research. 
These floors contain core research laboratories for rnonoclonal antibody production, 
oligonucleotide and peptide synthesis, gene cloning, DNA sequencing, high perforrnance 
liquid chrornatography, tissue culture, magnetic resonance spectroscopy. and electron 
rnicroscopy. The ninth floor houses the anirnal care facilities. The anchor technology for the 
BR1 is Positron Emission Tornography. Located on the bottorn floor of the BR!, the PET 
lmaging Center has the capacity to operate two PET Scanners and supply positron emitting 
isotopes for its own use, and that of other irnaging sites in the region. The cyclotron is an IBA 
1819 dual particle rnachine, while the existing PET Scanner is a GE Advance. 
The BRF recently received a grant frorn the United States Department of Energy to establish 
The Center for Biornedical Technology Innovation (CBTI). It will focus on the development of 
instrurnentation for rninirnally invasive procedures, including advanced irnaging technologies 
for individual self-care, telernedicine and rnedical robotics. 
Also, BRF scientists are involved in a Departrnent of Energy grant with Fermi National 
Laboratory, University of Washington (Seattle) and Science Application International 
Corporation to develop a rnore cost-effective way to produce radioisotopes for use in Positron 
Emission Tornography. The effort Centers around the use of a Helium-3 radio-frequency 
quadrupole (RFQ) accelerator presently housed at Fermi, soon to be transferred to the BRI. 
Figure 1. 
The PET lrnaging Center has been irnaging patients for less than a year. A schematic of the 
ground floor facility can be seen in figure 1. 
3 5 
Targetry 
Targetry is all IBA standard issue, with all targets external to the yoke. We have rnodified the 
[0-181Water Targets rninimally by adding a fixed volume target cornpression stack to the target 
vent line. We have also added pressure transducers to all targets and interfaced transducer 
output to the cornputer for real time display. Typical transrnissions on each of the beam ports 
can be found in Table 1. 
Table I 
Chernistry Modules 
We are using Siemens CPCU's for FDG production. Otherwise IBA rnodules are in use. 
Radiopharrnaceuticals and yields are displayed in Table 2. We are not yet licensed to produce 
0-15 because sorne shielding issues are yet to be resolved to the satisfaction of State regulatory 
bodies. 
Target 
TgtlStr 
Collimator 
Table 2 
17% N-13 content from p,pn reaction was subtracted to correct fw contaminah. 
Areas of Focus 
Clinical operation of our PET facility is our first priority at the moment. Frorn the cyclotron 
operation standpoint, this means supplying a reliable strearn of [F-18lFDG and [N-13lArnrnonia 
to our clinical CO-workers. We hope to branch into research applications and [F-18lFDG 
distribution in the near future (within 12 months). 
1 
C-I1 
91% 
16 
mm 
Our present efforts have therefore focused on reliable synthesis of obscene quantities of [F- 
18jFDG while sirnultaneously atternpting to meet the intensely stringent and stifling new FDA 
(Food and Drug Administration) regulations on the production of PET radiopharmaceuticals. 
Srnall target rnodifications have rnade an incredible difference to reliable F-18 production and 
[F-18JFDG synthesis. First we added pressure transducers to the target so that we could observe 
target dynamics during irradiation. In controlied experiments we found dramatic variations i n  
target pressures during irradiations depending upon the volume loaded of [O-181H20. Target 
yields correlated directly with the operating pressure. High pressure (>200 psi) resulted in high 
yields. low pressure ( 4 0 0  psi) resulted in low yields and problernatic target delivery. Initial 
stretching of the target foil following rebuild significantly affected target volurne, and therefore 
target perforrnance. Inconsistent loading volurnes also plagued reliable production. Our 
present solution requires careful rnonitoring of target pressures. We have found optimal results 
running at about 12 and at an operating pressure between 300-500 psi. We have also 
rnodified the target vent line so as to provide a reproducible cornpressible air space between 
the target and Rheodyne valve. This is shown schernaticalty in figure 2. This modification 
allows us to "overfiH" the target with the syringe, yet still maintain a compressible air space 
outside of the bearnstrike area to keep target pressures under control. 
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F-18 
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10 
rnrn 
3 
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Figure 2. F-18 Target Modification 
We are also beginning to concentrate on [N-13lammonia production. We have two problems 
which we are attempting to overcome. The first is pyrogenicity. Testing of our [N-13lammonia 
product has resulted in unacceptably high levels of pyrogens in some of our runs. We expect to 
solve this probiem by flushing the target and delivery lines thoroughly prior to bombardment, 
b$, we need to validate this. We also have detected some long lived Scandium isotopes 
( ' Sc from p.a on 47.50~i apparently leaching from the Titanium window. We are looking into 
further energy degradation of the proton beam to 11-12 MeV in the hopes of dropping below 
activation energies for these reactions. We would be interested in anyone's solutions to these 
problerns. 
Safety and Security Measures 
There are a number of safety interlocks wired into the cyclotron system both to protect the 
equipment and the personnel. For Radiation Safety purposes there are 4 "Scramn buttons 
placed all over the cyclotron laboratory and within the vault. Pressing any of the buttons shuts 
down and disables cyclotron power supplies. Two Nal stack monitors record any activity 
released to the atmosphere through the stack. Should the count rate at either of the Wo 
detectors exceed 2 X lo5  cpm, the cyclotron is shut down. A radiation monitoring system 
continually monitors dose rates in each of the rooms in the cyclotron, Scanner, and patient prep 
areas. Levels are logged automatically onto a computer every 15 seconds. The door to the 
cyclotron vault is both software and hardware interlocked. 
Primary water flow, primary water temperature and compressed air all have software interlocks 
built in (water temperature must be less than 58O F, and air compressor must be > 100 psi). 
Room temperature and relative humidity are also monitored. lf the level reaches 80% relative 
humidity or room temperature reaches 85" F the cyclotron shuts down. There is a newly 
installed helium flow interlock which prevents beam running on target if there is insufficient 
flow. 
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Major area of expertise is accelerator targetry. Broad knowledge of radiochernistry 
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experience. 
Contact regarding cyclotron targetry, chernistry, 
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Mike Fulcher - Cyclotron Engineer - rnfulch@rnail-sh.lsumc.edu 
Mike is a long time accelerator engineer. He does most of the "roll up your sleeves and 
get your hands dirty" cyclotron rnaintenance and upgrades. The major problern solver 
at our institution. 
Contact regarding cyclotron rnaintenance, cyclotron upgrades 
phone: 31 8.675.4008 
Susan Goebel - Chernistry Technologist - sgoebe@mail-sh.lsurnc.edu 
Susan is a chemistry technologist who has just recently entered the exciting and 
rewarding field of radiochernistry. At present she is perforrning our routine chernical 
synthesis of FDG and perforrning rnost of the quality control procedures. 
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THE CYCLOTRON AND RADIOCHEMISTRY FAClLlTlES IN ULM 
K. GRILLENBERGER, B. NEUMAIER, D. LUCKAU, S. N. RESKE 
DEPARTMENT OF NUCLEAR MEDICINE, UNlVERSlN HOSPITAL ULM, FRG 
I. lntroduction 
The University Hospital Ulm has a capacity of 1053 beds and consists of 45 departments. 37.398 in- 
patients were treated in the year 1995. The share of the Departrnent of Nuclear Medicine was 0.64 % 
(238 patients). In total 10.834 in- and outpatient nuclear medical diagnostics were performed. About 
40 medical, scientific and technical ernployees are working in the Department of Nucl. Med. at this 
time. The number of scientists amounts to 7 (2 chemists, 1 pharmacist, 1 biologist, 2 physicists and 1 
engineer). Since 1995 we are provided with a cyclotron and radiopharmaceutical laboratories. The 
rnedical section has two PET scanners (Siemens-CTI ECAT 931-08-12 and Siemens-CTI Exact HR*). 
Furthermore we are equipped with 5 different garnma cameras (partly SPECT). The main research 
area is cancer diagnosis besides cardiac and neurological questions. On this scope the developrnent 
of new reactions for the labeling of anticancer drugs with PET nuclides is an important intention. 
Another point of interest lays in the investigation of molecular biological fundarnentals for the 
metabolism of clinically used radiopharmaceuticals. In this connection we analyze the expression of 
distinct glucose transporter genes in different cancer tissues which are responsible for the elevated 
uptake of ["F]-FDG. Another molecular biological project deals with the labeling of DNA and RNA 
oligonucleotide antisense molecules with radioactive isotopes (mainly with PET nuclides). 
As we were able to start working with the cyclotron and radiochemistry facilities not before autumn 
1995 and because of unexpected problems with the exhausted activity using gaseous radioactive 
compounds (see below) we still are busy establishing and expanding the range of routinely produced 
radiopharmaceuticals. 
2. Radiopharmaceutical laboratories 
In Ulrn the radiopharmaceutical area is clearly separated from the medical section. The gamma 
carneras and the PET scanners are located at the second floor, the cold and hot laboratories are at 
the first floor, and the cyclotron is at level 0. Therefore the radioactive compounds have to cover 
considerable distances. Transfer from the target to the hot lab is realized through 1116" teflon tubes 
by helium pressure. The hot lab is connected with the scanner room by a pneumatic dispatch to 
transport the radiopharmaceuticals after quality control to the PET Scanner. The radiopharmaceutical 
facilities are divided into three radiation protection areas (Fig.2): 
- non controlled area: corridor, wmmon room, bathroorn 
- controlled area: office, control room, technical roorn. hot lab, quality wntrol room, cold lab, 
workshop, cyclotron vault (without beam) 
- prohibited area: cyclotron vault (with beam) 
3. Cyclone 1819 
At the rnoment 5 target positions of the cyclotron are installed, 3 are free (Tab. 1). 
Tab.1: Targetry and radiochemical yields of Cyclone 1819 in Ulm 
Chemistry test: 732 237 --- W 333 478 2110 
activity [rnci] (F) (02) F )  Wh (CO$ 
Dual beam at the exits 2 and 6 is possibie. All targets are frorn IBA, 
39 
Cyclone 1819 is norrnally running from Tuesday till Fnday, Monday we try to save for servicing andl 
repairs. Beam time is usually in the moming (dependent on medical demand). 
4. Chemistry modules 
We are equipped with the following chemistry modules from IBA: 
18 
- F-FDG module 
- 13N-NH3 module 
- "C-acetate module 
- "C-HCN moduie 
- 150-water module 
- 150 and "C CO/C02 gas module 
In addition we have a second "F-FDG module from the KFA Jülich and a ''C methylation module 
from Nuclear Interface. The chemistry modules are placed in 7 hot cells (Van Gahlen). 
As mentioned above, at the moment we have problems with the exhausted activity using volatile 
radioactive compounds because of unforeseen leakages of the hot cells. This is the reason why we 
are not yet allowed to produce and handle radioactive gases. In September 1996 a system will be 
installed to deposit the aspirated radioactive gases from the hot cell temporarily in gas cylinders 
before being let off into the ventilation system. So we can not give a report on our own experiences 
handling "C and 150 at this time. 
For almost one year we routinely produce 18F-, "F-FDG (4-5 days per week) and 13~-ammonia (2-3 
days per week). The (not decay corrected) radiochemical yield of the FDG production with the module 
from KFA Jülich is illustrated in Fig.1. Producing FDG with the IBA-I8F-FD~ module leads to much 
lower yields (c35 %), thats why we do not use this module for routine production. 
Fig.1: Radiochemical yield of I8F-FD~ (not decay corrected) in 1996 
5. Radiation protection, safety measures, environmental care 
The cyclotron vault is shielded by approx. 2 metres of a Special BaSOdjconcrete. Starting of the beam 
is inte~rated in an extemal interiock system consisting of different components: 
- Eme~gency stop buttons in all rooms. 
- Minimum pressure differente between cyclotron vault and technical room (20 Pa). 
- Monitoring of the seal-pressure in the cyclotron door, 
- Hot cell doos have to be closed for purging the target. 
All rooms of the controlled area and each of the 7 hot cells are radiation monitored which can be 
displayed in the control room. The entire waste air is also monitored continuously and must not 
exceed 200 Bqfcbm in the annual average. The waste water is separately collected and may not be 
drained off until falling below certain activity limits. 
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Fig.2: Layout of the radiopharmaceutical laboratories in Ulm 
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